Cargando…
The NLRP3 inflammasome: a new player in neurological diseases
Inflammasomes are supramolecular protein complexes implicated in the detection of pathogens or danger-associated molecules and are responsible for mounting the first line of innate immune response to counteract these signals and restore tissue homeostasis. Among different inflammasomes identified so...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Scientific and Technological Research Council of Turkey
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6911260/ https://www.ncbi.nlm.nih.gov/pubmed/31892810 http://dx.doi.org/10.3906/biy-1909-31 |
_version_ | 1783479231300239360 |
---|---|
author | EREN, Elif ÖZÖREN, Nesrin |
author_facet | EREN, Elif ÖZÖREN, Nesrin |
author_sort | EREN, Elif |
collection | PubMed |
description | Inflammasomes are supramolecular protein complexes implicated in the detection of pathogens or danger-associated molecules and are responsible for mounting the first line of innate immune response to counteract these signals and restore tissue homeostasis. Among different inflammasomes identified so far, NLRP3 is of main interest since mutations in Nlrp3 gene are associated with autoinflammatory diseases such as Muckle–Wells syndrome, neonatal onset multisystem inflammatory disease, and familial cold urticaria/autoinflammatory syndrome. On the other hand, whereas other inflammasomes are mainly detectors of specific molecular motifs, NLRP3 is acting as a general sensor of cellular perturbations including potassium efflux, lysosomal damage, and ROS production. Besides this central role of NLRP3 in inflammation, recent publications show that the NLRP3 inflammasome is also involved in the physiopathology of several neurological disorders including Alzheimer’s disease, Parkinson’s disease, and multiple sclerosis. This review gives an overview of the established functions of the NLRP3 inflammasome in mediating inflammation in macrophages and describes its recently discovered roles in neurological disorders in promoting neuroinflammation, as well as modulating key proteins mediating the disorders. Finally, we discuss the targeting of NLRP3 in neurological diseases and present some examples of NLRP3 inhibitors that could be used in neurological disorder treatments. |
format | Online Article Text |
id | pubmed-6911260 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | The Scientific and Technological Research Council of Turkey |
record_format | MEDLINE/PubMed |
spelling | pubmed-69112602019-12-31 The NLRP3 inflammasome: a new player in neurological diseases EREN, Elif ÖZÖREN, Nesrin Turk J Biol Article Inflammasomes are supramolecular protein complexes implicated in the detection of pathogens or danger-associated molecules and are responsible for mounting the first line of innate immune response to counteract these signals and restore tissue homeostasis. Among different inflammasomes identified so far, NLRP3 is of main interest since mutations in Nlrp3 gene are associated with autoinflammatory diseases such as Muckle–Wells syndrome, neonatal onset multisystem inflammatory disease, and familial cold urticaria/autoinflammatory syndrome. On the other hand, whereas other inflammasomes are mainly detectors of specific molecular motifs, NLRP3 is acting as a general sensor of cellular perturbations including potassium efflux, lysosomal damage, and ROS production. Besides this central role of NLRP3 in inflammation, recent publications show that the NLRP3 inflammasome is also involved in the physiopathology of several neurological disorders including Alzheimer’s disease, Parkinson’s disease, and multiple sclerosis. This review gives an overview of the established functions of the NLRP3 inflammasome in mediating inflammation in macrophages and describes its recently discovered roles in neurological disorders in promoting neuroinflammation, as well as modulating key proteins mediating the disorders. Finally, we discuss the targeting of NLRP3 in neurological diseases and present some examples of NLRP3 inhibitors that could be used in neurological disorder treatments. The Scientific and Technological Research Council of Turkey 2019-12-13 /pmc/articles/PMC6911260/ /pubmed/31892810 http://dx.doi.org/10.3906/biy-1909-31 Text en Copyright © 2019 The Author(s) This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use and redistribution provided that the original author and source are credited. |
spellingShingle | Article EREN, Elif ÖZÖREN, Nesrin The NLRP3 inflammasome: a new player in neurological diseases |
title | The NLRP3 inflammasome: a new player in neurological diseases |
title_full | The NLRP3 inflammasome: a new player in neurological diseases |
title_fullStr | The NLRP3 inflammasome: a new player in neurological diseases |
title_full_unstemmed | The NLRP3 inflammasome: a new player in neurological diseases |
title_short | The NLRP3 inflammasome: a new player in neurological diseases |
title_sort | nlrp3 inflammasome: a new player in neurological diseases |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6911260/ https://www.ncbi.nlm.nih.gov/pubmed/31892810 http://dx.doi.org/10.3906/biy-1909-31 |
work_keys_str_mv | AT erenelif thenlrp3inflammasomeanewplayerinneurologicaldiseases AT ozorennesrin thenlrp3inflammasomeanewplayerinneurologicaldiseases AT erenelif nlrp3inflammasomeanewplayerinneurologicaldiseases AT ozorennesrin nlrp3inflammasomeanewplayerinneurologicaldiseases |